ArticleGeroScience2026
Advanced brain age and longitudinal cognitive decline in healthy older adults.
Article in GeroScience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Advanced brain age relative to chronological age may predict cognitive decline in healthy aging, but prospective evidence remains limited. We tested whether the brain age gap (BAG) predicts cognition and 5-year cognitive decline in the AGES-Reykjavik Study. Participants with structural MRI and neuropsychological data were included cross-sectionally (n = 4,606); mean age 76.4y; 58% female) and longitudinally (n = 2,561; mean follow-up 5.2y). BAG was estimated from T1-weighted MRI. Mixed-effects models examined BAG effects on Memory (M), processing speed (PS), and executive function (EF), adjusting for age, sex, and education. Higher BAG was associated with worse cognition across all domains (β = -0.037 to -0.047, all p < 0.001). BAG significantly predicted greater decline in M (β = -0.007, p = 0.046); subgroup analyses revealed steeper decline in M and EF with advanced brain age. BAG predicts longitudinal cognitive decline beyond chronological age, supporting its utility as a biomarker in preventative care of healthy aging.
Indexed as
Identifiers
42911347What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.